TrialJournal of atherosclerosis and thrombosis2024
Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial.
Junya Ako et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.